Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Supriya Lifescience Bisoprolol Fumarate

    Virtual Booth

    Contact Supplier

    Bisoprolol

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Bisoprolol Fumarate

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Menu

    ZIAC

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 482Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Unique’s Generics Bisoprolol Fumarate Receives Approval in US
    Unique’s Generics Bisoprolol Fumarate Receives Approval in US

    24 Mar 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219489

    FDA
    24 Mar 2026
    Share Share
    Micro’s Generics Bisoprolol Fumarate Receives Approval in US
    Micro’s Generics Bisoprolol Fumarate Receives Approval in US

    09 Mar 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218303

    FDA
    09 Mar 2026
    Share Share
    Enforcement Report - Week of February 11, 2026
    Enforcement Report - Week of February 11, 2026

    11 Feb 2026

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-11-2026-78301.pdf

    FDA
    11 Feb 2026
    Share Share
    Aurobindo’s Generics Bisoprolol Fumarate Receives Approval in US
    Aurobindo’s Generics Bisoprolol Fumarate Receives Approval in US

    21 Jan 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217922

    FDA
    21 Jan 2026
    Share Share
    National Pharmaceutical Pricing Authority Sets Retail Prices
    National Pharmaceutical Pricing Authority Sets Retail Prices

    27 Dec 2025

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=183261&sid=1

    PHARMABIZ
    27 Dec 2025
    Share Share
    Enforcement Report - Week of December 10, 2025
    Enforcement Report - Week of December 10, 2025

    10 Dec 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-10-2025-13367.pdf

    FDA
    10 Dec 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.